Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/3613 stock hub

HKG/3613 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/3613is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.2B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/3613

In the news

Latest news · HKG/3613

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14

P25 11.7P50 18.9P75 41.4

Trailing P/E15.7

P25 10.7P50 17.9P75 38.5

ROE9.7

P25 -14.7P50 2P75 9.4

ROIC17.8

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/3613 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

HKD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Hong Kong
Country code	HK
Employees	780
Employees Change	-2%
Employees Change Percent	-0.26
Enterprise value	HKD 4.2B
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	HK0000145638
Last refreshed	2026-05-10
Market cap	HKD 6.2B
Price	HKD 7.44
Price currency	HKD
Rev Per Employee	1,940,201.28x
Sector	Healthcare
Sic	5912
Symbol	hkg/3613
Website	https://cm.tongrentang.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.38%
EV Earnings	10.69x
EV/EBIT	9.09x
EV/EBITDA	7.58x
EV/FCF	5.39x
EV/Sales	2.81x
FCF yield	12.66%
Forward P/E	14.04x
P/B ratio	1.43x
P/E ratio	15.68x
P/S ratio	4.12x
PE Ratio10 Y	16.09x
PE Ratio3 Y	15.44x
PE Ratio5 Y	15.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.45%
EBITDA Margin	32.74%
FCF margin	52.09%
Gross margin	61.16%
Gross Profit	HKD 925.6M
Gross Profit Growth	-14.03%
Gross Profit Growth Q	-24.61%
Gross Profit Growth3 Y	-2.28%
Gross Profit Growth5 Y	-5.45%
Net Income	HKD 397.2M
Net Income Growth	-20.6%
Net Income Growth Q	-42.12%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-7.02%
Net Income Growth5 Y	-10.64%
Pretax Margin	33.35%
Profit Margin	26.25%
Profit Per Employee	HKD 509,251
Profitable Years	14
ROA	6.45
Roa5y	9.84
ROCE	10.69
ROE	9.68
Roe5y	15.25
ROIC	17.83
Roic5y	32.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.37%
Cagr1y	-9.51%
Cagr3y	-19.25%
Cagr5y	-4.37%
Div CAGR10	11.9%
Div CAGR3	-11.65%
Div CAGR5	10.76%
EPS Growth	-20.6
EPS Growth Q	-42.12
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-7.02
EPS Growth5 Y	-10.64
Revenue Growth	-6.1x
Revenue Growth Q	-20.64x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	3.21x
Revenue Growth5 Y	-4.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.33
Assets	HKD 4.7B
Cash	HKD 2.3B
Current Assets	HKD 4.1B
Current Liabilities	HKD 206.8M
Debt	HKD 126.5M
Debt EBITDA	HKD 0.22
Debt Equity	HKD 0.03
Debt FCF	HKD 0.16
Equity	HKD 4.4B
Interest Coverage	84.1
Liabilities	HKD 291.9M
Long Term Assets	HKD 596M
Long Term Liabilities	HKD 85M
Net Cash	HKD 2.2B
Net Cash By Market Cap	HKD 34.74
Net Cash Growth	26.57%
Net Debt EBITDA	HKD -4.37
Net Debt Equity	HKD -0.5
Net Debt FCF	HKD -2.74
Tangible Book Value	HKD 4.1B
Tangible Book Value Per Share	HKD 4.93
WACC	6.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	19.65
Inventory Turnover	0.4
Net Working Capital	HKD 1.6B
Quick ratio	13.09
Working Capital	HKD 3.9B
Working Capital Turnover	HKD 0.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	14.29%
Dividend Growth Years	1%
Dividend per share	HKD 0.37
Dividend Years	13
Dividend Yield	4.97%
Ex Div Date	2026-06-12
Last Dividend	HKD 0.4
Payout Frequency	Annual
Payout Ratio	73.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	14.54%
1Y total return	-9.51%
200-day SMA	8.7
3Y total return	-47.35%
50-day SMA	7.97
50-day SMA vs 200-day SMA	50under200
5Y total return	-20.03%
All Time High	17.94
All Time High Change	-58.53%
All Time High Date	2018-05-29
All Time Low	4.7
All Time Low Change	58.3%
All Time Low Date	2013-05-07
ATR	0.13
Beta	0.4
Beta1y	0.38
Beta2y	0.33
Ch YTD	-12.06
High	7.46
High52	9.72
High52 Date	2025-08-26
High52ch	-23.46%
Low	7.33
Low52	7.23
Low52 Date	2026-05-05
Low52ch	2.91%
Ma50ch	-6.63%
Price vs 200-day SMA	-14.43%
RSI	39.36
RSI Monthly	37.2
RSI Weekly	26.99
Sharpe ratio	-0.5x
Sortino ratio	-0.42
Total Return	4.97%
Tr YTD	-12.06
Tr1m	-3.88%
Tr1w	1.5%
Tr3m	-16.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 476M
Operating Income Growth	-18.01
Operating Income Growth Q	-33.16
Operating Income Growth3 Y	-4.86
Operating Income Growth5 Y	-10.79
Operating margin	31.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	237,100,000%
Shares Institutions	3.46%
Shares Out	837,100,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 788.3M
Average Volume	866,179.1x
Bv Per Share	5
CAPEX	HKD -41.2M
Ch10y	-15.93
Ch1m	-3.88
Ch1w	1.5
Ch1y	-13.08
Ch3m	-16.03
Ch3y	-52.19
Ch5y	-32.36
Ch6m	-15.17
Change	0.81%
Change From Open	0.81
Close	7.38
Days Gap	0
Depreciation Amortization	18,817,000
Dollar Volume	7,001,040
Earnings Date	2026-05-13
EBIT	HKD 476M
EBITDA	HKD 495.5M
EPS	HKD 0.47
F Score	6
FCF	HKD 788.3M
FCF EV Yield	18.57x
FCF Per Share	HKD 0.94
Financing CF	-378,643,000
Fiscal Year End	December
Founded	1,669
Graham Number	7.30844
Graham Upside	-1.77
Income Tax	HKD 87.8M
Investing CF	-1,425,000
Is Primary Listing	1
Last Earnings Date	2026-03-20
Last Report Date	2025-12-31
Lynch Fair Value	HKD 2.37
Lynch Upside	-68.11
Ma150	8.52
Ma150ch	-12.64%
Ma20	7.51
Ma20ch	-0.92%
Net CF	454,773,000
Next Earnings Date	2026-05-13
Open	7.38
P FCF Ratio	7.9
P OCF Ratio	7.51
Payment Date	2026-06-26
Position In Range	84.62
Ppne	425,468,000
Price Date	2026-05-08
Price EBITDA	HKD 12.57
Ptbv Ratio	1.51
Relative Volume	1.1x
Revenue	1,513,357,000x
Tax By Revenue	5.8x
Tax Rate	17.4%
Tr6m	-15.17%
Volume	941,000
Z Score	17.67

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/3613 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.0%

$0.37 annual per share

Payout ratio

+73.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.8%

1 consecutive years of growth

Total shareholder yield

+5.0%

Next ex-dividend date: 2026-06-12

Performance

HKG/3613 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/3613?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.5%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/3613 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.4

Neutral momentum band

Price vs 200-day MA

-14.4%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

-0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/3613

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/3613 stock rating?

hkg/3613 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/3613 analysis?

The full report lives at /stocks/hkg/3613/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/3613?

The latest report frames hkg/3613 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/3613 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.